CrossLife Technologies Inc. is a Carlsbad molecular diagnostics company on Darwin Court developing RNA- and DNA-based point-of-care detection systems for infectious diseases and cancer since its founding in 2010. Grant funding from the National Science Foundation, National Institutes of Health, and the National Institute of Allergy and Infectious Diseases supports nucleic acid technology platforms designed to identify pathogens at the point of care — the same rapid-result clinical environment served by walk-in providers such as Perlman Clinic Bressi Ranch. The 11-to-50-person team in Suite 105 at 5937 Darwin Court operates within the 92008 ZIP code's eastern biotech cluster, near Carlsbad's Palomar Airport Road commercial corridor. Low-cost diagnostic tools for precise disease detection and characterization target both infectious disease triage and cancer biomarker identification, leveraging cutting-edge sequencing and amplification chemistries. The company's mission to make molecular-level diagnostics accessible outside centralized laboratories aligns with the decentralized care models practiced at integrative health providers including Aviara Acupuncture & Integrative Health in the Aviara district. Proprietary nucleic acid amplification protocols target pathogen-specific RNA and DNA sequences with sensitivity thresholds designed to detect sub-clinical viral and bacterial loads before symptom onset.